Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Notable companies reporting before tomorrow’s open
4h ago
CL
CVX
Premium
The Fly
AbbVie reports results from Phase 3 studies evaluating upadacitinib
1d ago
ABBV
Premium
Pre-Earnings
ABBV Earnings this Week: How Will it Perform?
2d ago
ABBV
Premium
The Fly
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
3d ago
LLY
MRK
Premium
Ratings
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
6d ago
ABBV
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
10d ago
ABBV
Premium
The Fly
AbbVie price target raised to $242 from $227 at Guggenheim
10d ago
ABBV
Premium
The Fly
AbbVie completes acquisition of Gilgamesh Pharmaceuticals’ bretisilocin
13d ago
ABBV
Premium
The Fly
AbbVie price target raised to $250 from $236 at Raymond James
13d ago
ABBV
Premium
The Fly
Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
14d ago
ABBV
ATAI
Premium
The Fly
Enveric hires firm to contest post-grant review petition filed by Gilgamesh
15d ago
ABBV
ENVB
Premium
The Fly
AbbVie downgraded to Hold from Buy at Erste Group
17d ago
ABBV
Premium
The Fly
AbbVie price target raised to $240 from $205 at Citi
17d ago
ABBV
Premium
The Fly
AbbVie announces FDA approval of updated indication statement for RINVOQ
17d ago
ABBV
Premium
The Fly
AbbVie to present new data from ADC platform at ESMO
17d ago
ABBV
Premium
The Fly
AbbVie price target raised to $284 from $231 at Piper Sandler
20d ago
ABBV
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
21d ago
ABBV
APYX
Premium
The Fly
AbbVie price target raised to $250 from $245 at Cantor Fitzgerald
21d ago
ABBV
Premium
The Fly
Aldeyra price target raised to $7 from $6 at Jefferies
22d ago
ABBV
ALDX
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 2 ELATE trial
24d ago
ABBV
Premium
The Fly
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
24d ago
ABBV
GILD
Premium
The Fly
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
27d ago
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
